Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Further Study of the Clinical Performance of AFGen1

NCT06335498 is registered in ClinicalTrials.gov with TriVirum, Inc. as lead sponsor.

NCT NCT06335498
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06335498 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Further Study of the Clinical Performance of AFGen1
Lead sponsor
TriVirum, Inc.
Phase
Observational
Overall status
Completed
Start date
April 2, 2024
Completion date
April 19, 2024
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

afib, atrial fibrillation, ecg